The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Philip N. Patsalos

Institute of Neurology/The National Hospital for Neurology and Neurosurgery

London and The Chalfont Centre for Epilepsy

Chalfont St Peter

United Kingdom

[email]@ion.ucl.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute of Neurology/The National Hospital for Neurology and Neurosurgery, London and The Chalfont Centre for Epilepsy, Chalfont St Peter, United Kingdom. 2003 - 2008
  • Institute of Neurology, Pharmacology and Therapeutics Unit, University Department of Clinical Neurology, London, UK. 2000 - 2006
  • Pharmacology and Therapeutics Unit, University Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, UK. 2000 - 2004
  • Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, Queen Square, UK. 2002 - 2003

References

  1. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Patsalos, P.N., Berry, D.J., Bourgeois, B.F., Cloyd, J.C., Glauser, T.A., Johannessen, S.I., Leppik, I.E., Tomson, T., Perucca, E. Epilepsia (2008) [Pubmed]
  2. In situ metabolism of levetiracetam in blood of patients with epilepsy. Patsalos, P.N., Ghattaura, S., Ratnaraj, N., Sander, J.W. Epilepsia (2006) [Pubmed]
  3. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Patsalos, P.N. Epilepsia (2005) [Pubmed]
  4. Clinical pharmacokinetics of levetiracetam. Patsalos, P.N. Clin. Pharmacokinet (2004) [Pubmed]
  5. The pharmacokinetic characteristics of levetiracetam. Patsalos, P.N. Methods. Find. Exp. Clin. Pharmacol (2003) [Pubmed]
  6. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Patsalos, P.N., Perucca, E. Lancet. Neurol (2003) [Pubmed]
  7. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Patsalos, P.N., Perucca, E. Lancet. Neurol (2003) [Pubmed]
  8. The importance of drug interactions in epilepsy therapy. Patsalos, P.N., Fröscher, W., Pisani, F., van Rijn, C.M. Epilepsia (2002) [Pubmed]
  9. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Patsalos, P.N. Pharmacol. Ther. (2000) [Pubmed]
  10. Anti-epileptic drugs: newly licensed and under development. Patsalos, P.N. IDrugs (2000) [Pubmed]
 
WikiGenes - Universities